DR. MARTIN L MAYSE, MD
Osteopathic Medicine at Childrens Pl, Saint Louis, MO

2007028, Dec 6, 2007

May 31, 2006

11/446086

Martin L. Mayse - University City MO, US

A61M 5/178

60416401, 60416402, 60416703

The present invention provides thoracentesis systems composed of an insertion needle, a thoracentesis catheter with self-sealing valve, and a valve opening device which are utilized in the removal of fluid or gases from a pleural cavity. The insertion needle is utilized to insert the thoracentesis catheter into the pleural cavity. The thoracentesis catheter provides automatic closure of the flow path from the pleural cavity by automatic closure of the self-sealing valve upon removal of the insertion needle from the thoracentesis catheter. The self-sealing valve prevents drainage of fluid from the pleural cavity and introduction of air into the pleural cavity when the needle is withdrawn from the thoracentesis catheter and a valve opening device is not in place. A drainage flow path from the pleural cavity is established by insertion of a valve opening device into the self-sealing valve of the thoracentesis catheter, thus opening the self-sealing valve. With the self-sealing valve opened by a valve opening device, fluid or gases can be removed from the pleural cavity.

2011011, May 19, 2011

Nov 11, 2010

12/944666

Martin L. Mayse - University City MO, US
Steven C. Dimmer - Bellevue WA, US

A61B 18/04, A61N 7/00

606 33, 601 2, 606 27

A system and method can be used to denervate at least a portion of a bronchial tree. An energy emitter of an instrument is percutaneously delivered to a treatment site and outputs energy to damage nerve tissue of the bronchial tree. The denervation procedure can be performed without damaging non-targeted tissue. Minimally invasive methods can be used to open airways to improve lung function in subjects with COPD, asthma, or the like. Different sections of the bronchial tree can be denervated while leaving airways intact to reduce recovery times.

2007007, Apr 5, 2007

Aug 23, 2006

11/466604

Martin Mayse - University City MO, US

A61M 39/00

604533000

The present invention is a tapered attachment for use with a pleural catheter that connects securely to the pleural catheter and has a hollow elongated member and a tapered distal portion. When the tapered attachment connected to the prior art catheter, the hollow elongated member opens the self-sealing valve of the prior art catheter allowing communication from the interior of the pleural catheter to the interior of the tapered attachment. The distal outer taper of the invention can connect to a variety of standard drainage systems to remove fluids or gases from the pleural cavity. The invention may also have a one way valve. With the invention in place and functioning, air does not enter the pleural space. Additionally, the variations in pleural pressure that normally occur during respiration can pump fluids or gases out of the pleural cavity through the invention.

2007005, Mar 8, 2007

Sep 1, 2006

11/469749

MARTIN MAYSE - University City MO, US
James Hummel - East Haven CT, US

A61F 7/00, A61F 7/12

607105000, 607113000

The present invention includes a device and a method for preventing injury of the esophagus during thermal ablation of the left atrium. The device has an esophageal probe with a balloon tip for insertion into the esophagus of a patient. During usage, coolant passes into the esophageal probe and then fills its balloon. The coolant, when circulating through the balloon and an external cooling machine, protects the esophageal tissue in contact with the esophageal probe from thermal damage during ablation of the posterior wall of the left atrium of the heart, or other procedure.

2012001, Jan 19, 2012

Sep 26, 2011

13/245537

Martin L. Mayse - University City MO, US
Steven C. Dimmer - Bellevue WA, US

Innovative Pulmonary Solutions, Inc. - Bellevue WA

A61B 18/14, A61B 18/12

606 41

Systems, delivery devices, and methods to treat to ablate, damage, or otherwise affect tissue. The treatment systems are capable of delivering a coolable ablation assembly that ablates targeted tissue without damaging non-targeted tissue. The coolable ablation assembly damages nerve tissue to temporarily or permanently decrease nervous system input.

2012031, Dec 13, 2012

Aug 13, 2012

13/584142

Martin L. Mayse - University City MO, US
Steven C. Dimmer - Bellevue WA, US

INNOVATIVE PULMONARY SOLUTIONS, INC. - Bellevue WA

A61B 18/18

606 33

Systems, assemblies, and methods to treat pulmonary diseases are used to decrease nervous system input to distal regions of the bronchial tree within the lungs. Treatment systems damage nerve tissue to temporarily or permanently decrease nervous system input. The treatment systems are capable of heating nerve tissue, cooling the nerve tissue, delivering a flowable substance that cause trauma to the nerve tissue, puncturing the nerve tissue, tearing the nerve tissue, cutting the nerve tissue, applying pressure to the nerve tissue, applying ultrasound to the nerve tissue, applying ionizing radiation to the nerve tissue, disrupting cell membranes of nerve tissue with electrical energy, or delivering long acting nerve blocking chemicals to the nerve tissue.

2012001, Jan 19, 2012

Sep 26, 2011

13/245529

Martin L. Mayse - University City MO, US
Steven C. Dimmer - Bellevue WA, US

Innovative Pulmonary Solutions, Inc. - Bellevue WA

A61B 18/14

606 41

Systems, delivery devices, and methods to treat to ablate, damage, or otherwise affect tissue. The treatment systems are capable of delivering a coolable ablation assembly that ablates targeted tissue without damaging non-targeted tissue. The coolable ablation assembly damages nerve tissue to temporarily or permanently decrease nervous system input.